VLX1570

Overview
Catalog #	bs-6985c-10mg-solid
Product Name	VLX1570
Specifications
Storage Buffer	Powder
Storage Condition	Store in dry, dark place at -20C for 1 year.
Target
Product Information	Molecular Weight: 469.39 Formula: C23 H17 F2 N3 O6 CAS Number: 1431280-51-1 InChi Key: SCKXBVLYWLLALY-CQRYCMKKSA-N InChi: InChI=1S/C23H17F2N3O6/c1-2-22(29)26-8-7-16(9-14-3-5-18(24)20(11-14)27(31)32)23(30)17(13-26)10-15-4-6-19(25)21(12-15)28(33)34/h2-6,9-12H,1,7-8,13H2/b16-9-,17-10- Smiles: C=CC(=O)N1C/C(=C/C2=CC(=C(F)C=C2)[N+]([O-])=O)/C(=O)/C(/CC1)=C\C1=CC(=C(F)C=C1)[N+]([O-])=O Purity: 98.0 Solubility: Soluble in DMSO, not in water Appearance: Solid Power. Shelf Life: 1.0 years
Description	VLX1570 is an inhibitor of the 19S proteasome-specific deubiquitylating enzymes (DUBs) USP14 and UCHL5, with apoptosis-inducing and antineoplastic activities. Upon administration, VLX1570 specifically binds to both USP14 and UCHL5, thereby blocking their deubiquitylating activity. This blocks the ubiquitin proteasome degradation pathway, prevents the degradation of defective proteins, and leads to an accumulation of poly-ubiquitylated proteins. This induces the unfolded protein response (UPR) and results in both the induction of tumor cell apoptosis and the inhibition of tumor cell growth.